Beyond the Initial Cure: Expanding the Horizons of Orphan Drug Indications

Описание к видео Beyond the Initial Cure: Expanding the Horizons of Orphan Drug Indications

Stanford Biodesign Policy Fellow, Erika Modina, moderated a discussion on rare disease treatments and how legislative efforts like the Inflation Reduction Act and the Orphan Cures Act could impact the balance required between innovation, affordability, and access.

Panelists:
Mason Barrett, Policy Analyst, National Organization for Rare Disorders (NORD)
Jon Brodo, Policy Director, Todd Strategy
Cartier Esham, PhD, Chief Scientific Officer & EVP of Emerging Companies, Biotechnology Innovation Organization (BIO)

Комментарии

Информация по комментариям в разработке

Похожие видео